Investing

The company utilizes machine learning and patient data to deliver personalized medication management pertaining to polypharmacy.

It expects continued long-term growth in the demand for virtual care services post-pandemic.

The company will use the investment to fuel the expansion of Paradigm,its FDA-cleared, AI-enabled surgical navigation platform.

The multiple sclerosis-focused company will use the funds to speed up the company's commercialization efforts.

GenHealth AI, maker of what it calls a large medical model, and senior-focused startup K4Connnect also secured investment.

Mental health company UpLift and electrophysiology-focused medical technology company CathVision also garnered investment.

The senior debt facility is part of Amino's $80 million in equity and debt financing received in May.

The round brings the company's total raise to $93 million.

Naomi Fried, founder and CEO of PharmStars, discusses the 13 startups from its spring cohort and its call for applications for its fall 2023 cohort, Digital Innovations in Therapeutic Delivery: Supply Chain to the Patient Interface.

The company will use the funds to speed up its growth.